Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gustafson

Showing results (611-620 of 634) with videos related to

Pageof 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerSeth P Lerner, David J McConkey, Catherine M Tangen, et al.
Nature|July 11, 1996
A receptor subtype involved in neuropeptide-Y-induced food intakeC Gerald, M W Walker, L Criscione, et al.
Journal of Medicinal Chemistry|December 2, 1999
3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activitiesD A Johnson, D S Keegan, C G Sowell, et al.
European Urology|July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
American Journal of Hematology|March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaHeather L Gustafson, Song Yao, Bryan H Goldman, et al.
Journal of Fish Diseases|November 22, 2017
A systematic surveillance programme for infectious salmon anaemia virus supports its absence in the Pacific Northwest of the United StatesL L Gustafson, L H Creekmore, K R Snekvik, et al.
Journal of Medicinal Chemistry|November 2, 2019
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal CancerAdedoyin D Abraham, Hector Esquer, Qiong Zhou, et al.
The Journal of Endocrinology|April 9, 2005
Transgenic overexpression of neuromedin U promotes leanness and hypophagia in miceT J Kowalski, B D Spar, L Markowitz, et al.
Pageof 64

Showing results (611-620 of 634) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2023
Association of Molecular Subtypes with Pathologic Response, PFS, and OS in a Phase II Study of COXEN with Neoadjuvant Chemotherapy for Muscle-invasive Bladder CancerSeth P Lerner, David J McConkey, Catherine M Tangen, et al.
Nature|July 11, 1996
A receptor subtype involved in neuropeptide-Y-induced food intakeC Gerald, M W Walker, L Criscione, et al.
Journal of Medicinal Chemistry|December 2, 1999
3-O-Desacyl monophosphoryl lipid A derivatives: synthesis and immunostimulant activitiesD A Johnson, D S Keegan, C G Sowell, et al.
European Urology|July 6, 2023
Long-term Outcomes from a Phase 2 Study of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer (SWOG S1314; NCT02177695)Thomas W Flaig, Catherine M Tangen, Siamak Daneshmand, et al.
Breast Cancer Research : BCR|August 4, 2018
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancerJennifer R Diamond, S G Eckhardt, Todd M Pitts, et al.
The Journal of Infectious Diseases|June 6, 2018
Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus CoinfectionAnna Lidofsky, Jacinta A Holmes, Eoin R Feeney, et al.
American Journal of Hematology|March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphomaHeather L Gustafson, Song Yao, Bryan H Goldman, et al.
Journal of Fish Diseases|November 22, 2017
A systematic surveillance programme for infectious salmon anaemia virus supports its absence in the Pacific Northwest of the United StatesL L Gustafson, L H Creekmore, K R Snekvik, et al.
Journal of Medicinal Chemistry|November 2, 2019
Drug Design Targeting T-Cell Factor-Driven Epithelial-Mesenchymal Transition as a Therapeutic Strategy for Colorectal CancerAdedoyin D Abraham, Hector Esquer, Qiong Zhou, et al.
The Journal of Endocrinology|April 9, 2005
Transgenic overexpression of neuromedin U promotes leanness and hypophagia in miceT J Kowalski, B D Spar, L Markowitz, et al.
Pageof 64